Public Health England has released updated guidance on Candida auris, as they confirm that over 200 patients have been infected or colonized with the fungus.
Browsing: Clinical > Clinical Diseases
An analysis of a large, nationwide health insurance database reveals a rapid increase in multiple recurring Clostridium difficile infections in the United States.
Researchers demonstrate how one of the deadliest hospital-acquired infections can be prevented by training and culture-change interventions.
A novel type of wound dressing that combines both hydrogel dressings and chitosan could reduce the risk of bacterial infection in recovering patients.
In this editorial the authors offer a perspective about issues surrounding the implementation of molecular antibiograms in the diagnostic workflow.
New research suggests it may be possible to quickly and accurately diagnose drug-resistant bacteria utilizing equipment already owned by hospitals.
In research presented at ECCMID 2017, scientists have suggested foods should be investigated as potential source of C. difficile.
This study delves aims to evaluate the efficacy of durancin 61A as an inhibitor of resistant clinical pathogens and to shed light on its mode of action.
This perspective discusses the urgent need for novel and efficient antimicrobial strategies against C. difficile and the authors evaluate the application of the acyldepsipeptides family of antibiotics to treat C. difficile infections.